Prevention of NSAID-Associated Gastrointestinal Lesions: A Comparison Study Pantoprazole<i>versus</i>Omeprazole
Jarosław Reguła(The Maria Sklodowska-Curie National Research Institute of Oncology), Renate Fischer(Fischer (Germany)), C.P.M. Dekkers(Fischer (Germany)), Sybrand Y. de Boer(Rijnstate Hospital), Dieter Raps(Fischer (Germany)), L Simón(Fischer (Germany)), Kathy B. Thomas(Fischer (Germany)), Andreas Terjung(Fischer (Germany)), E Butruk(Foundation for Polish Science), Reinhold Lühmann(Fischer (Germany))
Cited by 65
Related Papers
Quality Indicators for Colonoscopy and the Risk of Interval Cancer
|New England Journal of Medicine|2010|2k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
|Endoscopy|2017|1.1k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Colonoscopy in Colorectal-Cancer Screening for Detection of Advanced Neoplasia
|New England Journal of Medicine|2006|790